SkinBit Lands $6M Pre-Seed for Full-Body Skin Cancer Scanner

SkinBit, a healthcare startup building a full-body scanner for skin cancer screening, has raised $6 million in pre-seed funding. The round was announced on August 5, 2026. No lead investors were disclosed.

The company has designed a system that uses advanced camera arrays and controlled lighting to capture head-to-toe images of a patient’s skin. The goal is to create a standardized, trackable record that helps dermatologists spot new or changing moles and lesions earlier than a routine visual exam might allow. Each scan is non-invasive, involves no radiation, and is reviewed by a board-certified dermatologist, with results returned within 48 hours.

SkinBit operates on an annual membership model priced at $499 per year. The fee covers unlimited scans and dermatologist-reviewed imaging. The company says the service is built to provide “long-term visibility into your skin health,” mapping every mark and documenting every change across visits. Patients can choose how much of their body is imaged during a private-room session.

The clinical leadership behind SkinBit includes several physicians with deep experience in melanoma and digital dermatology. Co-founder Justin Ko serves as Chief of Medical Dermatology at Stanford Hospital and has published research on AI applications in dermatology. Dr. Sancy Leachman, the company’s Chief Medical Officer, is a former Chair of Dermatology at Oregon Health & Science University. She previously led Oregon’s “War on Melanoma” campaign, during which the state’s melanoma death rate dropped from the fourth-highest in the nation to thirty-first, a 41 percent decrease. Dr. Leachman also created MoleMapper, an Apple ResearchKit app that produced one of the world’s largest public collections of skin images for AI research.

Other advisors include Suephy Chen, Chief of Dermatology at Thomas Jefferson North Region and Asplundh Cancer Center, who helped establish national standards for not re-excising moderately dysplastic nevi, and Clara Curiel-Lewandrowski, a pioneer in total-body digital imaging and co-director of the University of Arizona Skin Cancer Institute.

The funding arrives as interest in technology-assisted dermatology grows. Melanoma remains the deadliest form of skin cancer, and early detection is closely tied to survival rates. Full-body imaging services have historically been available only in a handful of academic medical centers. SkinBit aims to make routine, trackable scans accessible through physical locations where patients can book appointments and receive dermatologist-reviewed reports without waiting months for a specialist visit. The company is accepting waitlist sign-ups but has not yet disclosed how the $6 million will be deployed across clinic openings, engineering, or regulatory steps.